封面
市场调查报告书
商品编码
1674127

肾臟病诊断市场(按检测类型、产品类型、最终用户和地区划分)

Preeclampsia Diagnostics Market, By Test Type, By Product Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 188 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球肾臟病诊断市场规模估计为 23.2 亿美元,预计到 2032 年将达到 46 亿美元,2025 年至 2032 年的复合年增长率为 10.3%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 23.2亿美元
效能资料 从2020年到2024年 预测期 2025年至2032年
预测期:2025-2032年复合年增长率: 10.30% 2032年价值预测 46亿美元
数字。 2025 年肾臟病诊断市场占有率(%)(按地区划分)
子痫前症诊断市场-IMG1

肾臟病症是一种妊娠併发症,其特征是妊娠 20 週后出现高血压和尿液中出现蛋白质。如果未被发现,对母亲和胎儿都可能造成危险。早期诊断至关重要,这样临床医生就可以密切监测病情,并在肾臟病恶化时分娩婴儿。传统的诊断方法依赖临床症状和体征,具有局限性。随着人们对子痫前症的认识不断提高,全球肾臟病诊断市场可能会持续成长。已经开发并采用了多种新的诊断工具来筛检有风险的女性并及时发现疾病。

市场动态:

全球肾臟病诊断市场的成长是由全球肾臟病的不断上升所推动的。根据最近的估计,全球整体约有 5-8% 的怀孕会罹患肾臟病。初次生育的母亲年龄不断增加也是导致病例增加的原因之一。新产品的推出和早期筛检先进诊断技术的日益普及为市场成长提供了机会。然而,低收入地区对肾臟病的认识不足和缺乏全民健康覆盖可能会阻碍市场成长。新诊断设备的高成本可能是一个挑战,尤其是在对价格敏感的新兴市场。

本研究的主要特点

  • 本报告对全球肾臟病诊断市场进行了详细分析,并给出了预测期(2025-2032 年)的市场规模(十亿美元)和年复合成长率(CAGR%),假设 2024 年为基准年。
  • 它还强调了各个领域的潜在商机,并解释了该市场的引人注目的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 本报告根据公司亮点、产品系列、关键亮点、绩效和策略等参数,概述了全球肾臟病诊断市场的主要企业。
  • 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
  • 全球肾臟病诊断市场报告迎合了该行业的各个相关人员,例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 可以透过分析全球肾臟病诊断市场中使用的各种策略矩阵来促进相关人员的决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 主要进展
  • 监管情景
  • 收购与合作场景
  • 资金筹措与投资
  • PEST分析
  • 波特的分析

4. 全球肾臟病诊断市场-冠状病毒(COVID-19)大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 市场影响

5. 2020-2032 年全球肾臟病诊断市场(按检测类型划分)(十亿美元)

  • 血液检查
  • 尿液检查
  • 其他的

6. 2020-2032 年全球肾臟病诊断市场(按产品类型划分)(十亿美元)

  • 装置
  • 耗材

7. 2020-2032 年全球肾臟病诊断市场(按最终用户划分)(十亿美元)

  • 医院
  • 专科诊所
  • 诊断中心
  • 其他的

8. 2020-2032 年全球肾臟病诊断市场(按地区划分)(十亿美元)

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第九章竞争格局

  • 公司简介
    • Roche Diagnostic
    • Thermo Fisher Giving Inc.
    • PerkinElmer
    • Siemens Healthineers
    • Abbott Laboratories
    • Beckman Coulter
    • Becton, Dickinson and Company(BD)
    • bioMerieux
    • F. Hoffmann-La Roche Ltd
    • Metabolomic Diagnostics Ltd
    • Diabetomics, Inc.
    • Quidel Corporation
    • Sera Prognostics
    • Brahms GmbH
    • The Progenix Group

第 10 章分析师建议

  • 机会
  • 分析师观点
  • Coherent Opportunity Map

第 11 章参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI4606

Global Preeclampsia Diagnostics Market is estimated to be valued at USD 2.32 Bn in 2025 and is expected to reach USD 4.60 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2.32 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 10.30% 2032 Value Projection: USD 4.60 Bn
Figure. Preeclampsia Diagnostics Market Share (%), By Region 2025
Preeclampsia Diagnostics Market - IMG1

Preeclampsia is a pregnancy complication characterized by high blood pressure and presence of protein in the urine after 20 weeks of gestation. It can be a dangerous condition for both mother and baby, if undetected. Early diagnosis is crucial to allow clinicians to closely monitor the condition and deliver the baby if preeclampsia worsens. Traditional diagnostic methods rely on clinical signs and symptoms, which have limitations. Global preeclampsia diagnostics market can witness growth due to increasing awareness about the condition. Various new diagnostic tools are being developed and adopted to screen women at risk and enable timely identification of the disorder.

Market Dynamics:

Global preeclampsia diagnostics market growth is driven by growing incidence of preeclampsia worldwide. According to recent estimates, preeclampsia complicates around 5-8% of all pregnancies globally. Rising maternal age of first-time mothers can contribute to its rising caseload. New product launches and increasing adoption of advanced diagnostic technologies for early screening can offer opportunities for market growth. However, limited awareness about preeclampsia in low income regions and lack of universal healthcare can hamper the market growth. High cost of new diagnostic devices can pose challenge, especially in price-sensitive developing markets.

Key Features of the Study:

  • This report provides in-depth analysis of the global preeclampsia diagnostics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global preeclampsia diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Roche, Thermo Fischer Scientific, Bayer, Siemens Healthineers, DRG Instruments GmbH
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global preeclampsia diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preeclampsia diagnostics market

Detailed Segmentation-

  • By Test Type
    • Blood Tests
    • Urine Analysis
    • Others
  • By Product Type
    • Instruments
    • Consumables
  • By End User
    • Hospital
    • Specialty Clinics
    • Diagnostic Centers
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Roche Diagnostic
    • Thermo Fisher Giving Inc.
    • PerkinElmer
    • Siemens Healthineers
    • Abbott Laboratories
    • Beckman Coulter
    • Becton, Dickinson and Company (BD)
    • bioMerieux
    • Hoffmann-La Roche Ltd
    • Metabolomic Diagnostics Ltd
    • Diabetomics, Inc.
    • Quidel Corporation
    • Sera Prognostics
    • Brahms GmbH
    • The Progenix GrouP

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Test Type
    • Market Snapshot, By Product Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Preeclampsia Diagnostics Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Preeclampsia Diagnostics Market, By Test Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Blood Tests
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Urine Analysis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Preeclampsia Diagnostics Market, By Product Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Instruments
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Consumables
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Preeclampsia Diagnostics Market, By End User, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Hospital
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Specialty Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Diagnostic Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Preeclampsia Diagnostics Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Roche Diagnostic
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Thermo Fisher Giving Inc.
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • PerkinElmer
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Siemens Healthineers
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Abbott Laboratories
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Beckman Coulter
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Becton, Dickinson and Company (BD)
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • bioMerieux
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • F. Hoffmann-La Roche Ltd
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Metabolomic Diagnostics Ltd
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Diabetomics, Inc.
    • Quidel Corporation
    • Sera Prognostics
    • Brahms GmbH
    • The Progenix Group

10. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About Us and Sales Contact